Monthly Archives: November 2010

CI & Patent News:30/11/2010

1) Paragraph IV litigation Astrazeneca Vs Mylan (product: Quetiapine ER) Patent in suit: 5948437 (Expiry: May 28, 2017); Complaint filed at Northern District of West Virginia on Nov. 29, 2010. View on PriorSmart Alza Corporation  Vs Impax Laboratories Inc & teva (Product: Methylphenidate ER) Patent … Continue reading

Posted in Daily interesting IP news, Patent case | Tagged , , , , | Leave a comment

CI & Patent News: 29/11/2010

1)  Actavis launches Docetaxel single vial on patent expiry in major European markets (Press Release) …. launched by Actavis under its own brand in Germany, the Netherlands, UK and Sweden, as well as by Medis ― the company’s sales division … Continue reading

Posted in Daily interesting IP news | Tagged , , , , , | Leave a comment

Cladribine Merck Oral Multiple Sclerosis therapy

Merck has developed oral therapy for relapsing forms of multiple sclerosis (MS). Cladribine is earlier known for treatment of cancer (leukemia) in intravenous administration. Now Merck licensing from Ivax (Teva subsidiary) has developed oral therapy for MS. This product is now at … Continue reading

Posted in Daily interesting IP news | Leave a comment

CI & Patent News:26/11/2010

Pronova BioPharma receives Lovaza(TM) Paragraph IV Notice Letter from Apotex Inc (Press release) Impax Laboratories Confirms Patent Challenge Relating to SIMCOR® Extended-Release Tablets, 1000/20 mg (link) Paragraph IV litigation: 1) Merck & Co., Inc Vs Hetero Drugs & Invagen Pharmaceuticals (No … Continue reading

Posted in Daily interesting IP news | Tagged , , , , , , , | Leave a comment

CI & Patent News: 24/11/2010

1) GlaxoSmithKline and Dr. Reddy’s Agree to the Sale of US Penicillin Facility and Products (Link) … Under the agreement, GSK will transfer ownership of its penicillin manufacturing site in Bristol, Tennessee, United States, and rights for the Augmentin® and … Continue reading

Posted in Daily interesting IP news | Tagged , , , , , , | Leave a comment

CRCT & Schering has sued Accord Healthcare Temodar

Cancer Research Technology Limited & Schering has sued Accord Healthcare on US Patent 5260291. Product: Temodar Capsule (Temozolomide). Note: Teva is the first to file ANDA holder. In the Paragraph litigation district court had held ‘291 patent invalid due to … Continue reading

Posted in Patent case | Tagged , , , | Leave a comment

CI & Patent News: 23/11/2010a

1) Vertex Completes New Drug Application for Telaprevir for Hepatitis C (Link) 2) Gilead Sciences Submits New Drug Application to U.S. FDA for Once-Daily Single-Tablet Regimen of Truvada® (emtricitabine and tenofovir disoproxil fumarate)and TMC278 (rilpivirine hydrochloride) for HIV (Link) 3) Wockhardt Ltd. has … Continue reading

Posted in Daily interesting IP news | Tagged , , , | Leave a comment

CI & Patent News: 23/11/2010

1) Paragraph IV Litigation: 1) Daiichi Sankyo & Genzyme Vs Impax & Glenmark Pharma Product: Colesevelam; Complaint No: 1:10-cv-00997-UNA. Genzyme has sued only on two product patents mentioned below Patent No Expiry Title 5,607,669: html | pdf Dec 10, 2014 Amine polymer sequestrant … Continue reading

Posted in Daily interesting IP news | Leave a comment

CI & Patent News: 22/11/2010

1) Paragraph IV Litigation: Impax Confirms Patent Challenge Relating to WELCHOL® (Colesevelam HCl) for Oral Suspension, 3.75 gm/packet and 1.875 gm/packet (Link). Colesevelam is bile acid sequestrant.  Genzyme is originator for Colesevelam and is marketed by Daiichi sankyo in USA. Colesevelam is co … Continue reading

Posted in Daily interesting IP news | Tagged , , , | Leave a comment

CETP inhibitor Patent status

In addition to my previous post on CETP inhibitors, i here present patent status of some companies who involved in development of CETP inhibitor class of drugs. The method of using CETP inhibitors for treating atherosclerosis and cardiovascular conditions, were known … Continue reading

Posted in Drug developments & targets | Tagged , , | Leave a comment